References
- Adam K S, Bianchi G, Hawker F, Nairn L, Sanford M, Scarr G. Interpersonal factors in suicide attempts: a pilot study in Christchurch. Australian and New Zealand Journal of Psychiatry 1978; 12: 59–63
- Adam K S, Bouckoms A, Scarr G. Attempted suicide in Christchurch: a controlled study. Australian and New Zealand Journal of Psychiatry 1980; 14: 305–314
- Khan A, Joyce P R, Jones A V. Benzodiazepine withdrawal syndromes. New Zealand Medical Journal 1980; 92: 94–96
- Pilowsky I. A general classification of abnormal illness behaviours. British Journal of Medical Psychology 1978; 51: 131–137
- Joyce P R, Bushnell J A, Walshe J W, Morton J B. Abnormal illness behaviour and anxiety in acute non-organic abdominal pain. British Journal of Psychiatry 1986; 149: 57–62
- McGuire M, Troisi A. Darwinian psychiatry. Oxford University Press, New York 1998
- Stevens A, Price J. Evolutionary psychiatry: a new beginning. Routledge, London 1996
- Popper K R. Unended quest: an intellectual autobiography. Fontana, Glasgow 1976
- Joyce P R. Age of onset in bipolar affective disorder and misdiagnosis as schizophrenia. Psychological Medicine 1984; 14: 145–149
- Joyce P R. Parental bonding in bipolar affective disorder. Journal of Affective Disorders 1984; 7: 319–324
- Joyce P R, Donald R A, Nicholls M G, Livesey J H, Abbot R M. Endocrine and behavioural responses to methylphenidate in depression. Psychological Medicine 1986; 16: 531–540
- Joyce P R, Donald R A, Elder P A. Individual differences in plasma cortisol changes during mania and depression. Journal of Affective Disorders 1987; 12: 1–5
- Wells J E, Bushnell J A, Hornblow A R, Joyce P R, Oakley-Browne M A. Christchurch psychiatric epidemiology study part I: methodology and lifetime prevalence for specific psychiatric disorders. Australian and New Zealand Journal of Psychiatry 1989; 23: 315–326
- Weissman M M, Bland R C, Canino G J, et al. Cross-national epidemiology of major depression and bipolar disorder. Journal of the American Medical Association 1996; 276: 293–299
- Joyce P R, Paykel E S. Predictors of drug response in depression. Archives of General Psychiatry 1989; 46: 89–99
- Kendell R E. The role of diagnosis in psychiatry. Blackwell, London 1975
- van Praag H M. Growth and inflation in psychiatry: progress against the odds. Comprehensive Psychiatry 1981; 22: 114–123
- van Praag H M. The scientific foundation of anti-psychiatry. Acta Psychiatrica Scandinavica 1978; 58: 113–141
- Cloninger C R. A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatric Developments 1986; 4: 167–226
- Cloninger C R. A systematic method for clinical description and classification of personality variants: a proposal. Archives of General Psychiatry 1987; 44: 573–588
- Cloninger C R. Neurogenetic adaptive mechanisms in alcoholism. Science 1987; 236: 410–416
- Joyce P R, Mulder R T, Cloninger C R. Temperament predicts clomipramine and desipramine response in major depression. Journal of Affective Disorders 1994; 30: 35–46
- Mulder R T. Why study the history of psychiatry?. Australian and New Zealand Journal of Psychiatry 1993; 27: 556–559
- Mulder R T. Boundaries of psychiatry. Perspectives in Biology and Medicine 1992; 35: 443–459
- Mulder R T. The biology of personality. Australian and New Zealand Journal of Psychiatry 1992; 26: 364–376
- Sellman J D, Mulder R T, Sullivan P F, Joyce P R. Low persistence predicts relapse in alcohol dependence following treatment. Journal of Studies on Alcohol 1997; 58: 257–263
- Sellman J D, Sullivan P F, Dore D M, Adamson S J, MacEwan I. A randomised controlled trial of motivational enhancement therapy (MET) for alcohol dependence. Journal of Studies on Alcohol 2001; 62: 389–396
- Bulik C M, Sullivan P F, Carter F A, McIntosh V V, Joyce P R. The role of exposure with response prevention in the cognitive-behavioural therapy for bulimia nervosa. Psychological Medicine 1998; 28: 611–623
- Joyce P R. The medical model: why psychiatry is a branch of medicine. Australian and New Zealand Journal of Psychiatry 1980; 14: 269–278
- Parker G, Tupling H, Brown L BA. Parental bonding instrument. British Journal of Medical Psychology 1979; 52: 1–10
- Parker G, Hadzi-Pavlovic D, Wilhelm K, et al. Defining melancholia: properties of a refined sign-based measure. British Journal of Psychiatry 1994; 164: 316–326
- Parker G. Classifying depression: should paradigms lost be regained?. American Journal of Psychiatry 2000; 157: 1195–1203
- van Praag H M. The diagnosis of depression in disorder. Australian and New Zealand Journal of Psychiatry 1998; 32: 767–772
- van Praag H M. Two-tier diagnosing in psychiatry. Psychiatry Research 1990; 34: 1–11
- Beautrais A L, Joyce P R, Mulder R T, Fergusson D M, Deavoll B J, Nightingale S K. Prevalence and comorbidity of mental disorders in persons making serious suicide attempts: a case-control study. American Journal of Psychiatry 1996; 153: 1009–1014
- Fergusson D M, Horwood L J. The Christchurch health and development study: review of findings on child and adolescent mental health. Australian and New Zealand Journal of Psychiatry 2001; 35: 287–296
- McIntosh V V, Bulik C M, McKenzie J M, Luty S E, Jordan J. Interpersonal psychotherapy for anorexia nervosa. International Journal of Eating Disorders 2000; 27: 125–139
- Sullivan P F, Fifield W J, Kennedy M A, Mulder R T, Sellman J D, Joyce P R. No association between novelty seeking and the type 4 dopamine receptor gene (DRD4) in two New Zealand samples. American Journal of Psychiatry 1998; 155: 98–101
- Pettigrew J D, Miller S M. A ‘sticky’ interhemispheric switch in bipolar disorder? Proceedings of the Royal Society of London: series B. Biological Sciences. 1998; 265: 2141–2148
- Mulder R T, Ang M, Chapman B, Ross A, Stevens I F, Edgar C. Interferon treatment is not associated with a worsening of psychiatric symptoms in patients with hepatitis C. Journal of Gastroenterology and Hepatology 2000; 15: 300–303
- Charney D S. The use of placebos in randomized clinical trials of mood disorders: well justified, but improvements in design are indicated. Biological Psychiatry 2000; 47: 687–688
- Hyman S E, Shore D. An NIMH perspective on the use of placebos. National Institute of Medical Health. Biological Psychiatry 2000; 47: 689–691
- Krishnan K R. Efficient trial designs to reduce placebo requirements. Biological Psychiatry 2000; 47: 724–726
- Joyce P R, Mulder R T, Luty S E, et al. Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline. Australian and New Zealand Journal of Psychiatry 2002; 36: 384–391
- Hughes J R, Krahn D. Blindness and the validity of the double-blind procedure. Journal of Clinical Psychopharmacology 1985; 5: 138–142
- White K, Kando J, Park T, Waternaux C, Brown W A. Side effects and the ‘blindability’ of clinical drug trials. American Journal of Psychiatry 1992; 149: 1730–1731